Skip to main content

Augmenting Meds With Phone App Boosts Opioid Addiction Recovery Success

By Elana Gotkine HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on Jan 3, 2025.

via HealthDay

THURSDAY, Jan. 2, 2025 -- Augmenting medication for opioid use disorder (MOUD) with smartphone app-based contingency management (CM) is beneficial for uninsured or underinsured adults, according to a study published online Dec. 2 in JAMA Network Open.

Elise N. Marino, Ph.D., from the University of Texas Health Science Center at San Antonio, and colleagues examined whether augmenting MOUD with app-based CM is associated with days of opioid use at the end of treatment in a retrospective cohort study. The cohort included 600 individuals aged 18 years or older who were uninsured or underinsured and chose to receive MOUD only or MOUD plus CM delivered via a smartphone app (300 in each treatment group). On achieving their self-chosen recovery goals, participants who chose to receive app-based CM received monetary incentives.

The researchers found that compared with those who chose to receive MOUD only, those who chose to receive MOUD plus app-based CM reported significantly fewer days of opioid use at the end of treatment (mean duration, 8.4 versus 12.0 days; β = −6.10). Patients who chose to receive MOUD plus app-based CM were more likely to stay in treatment for longer than those who chose to receive MOUD only, according to retention analyses (mean duration, 290.2 versus 236.1 days; β = 51.91).

"Despite the challenges of engaging patients in other app-based interventions, adding recovery-oriented, app-based CM may be one way to enhance clinical care and meet the growing needs of historically underserved patients taking MOUD," the authors write.

One author received grants from KIOS/Biomedical Development Corp.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Read this next

Most People With Cannabis Use Disorder Remain Untreated

MONDAY, June 9, 2025 -- Most individuals in the United States with cannabis use disorder (CUD) do not receive treatment, according to a study published online May 19...

2021 to 2023 Saw Rise in Cannabis Use by Older Adults

THURSDAY, June 5, 2025 -- From 2021 to 2023, the prevalence of current cannabis use increased among older U.S. adults, according to a research letter published online June 2...

Chronic Cannabis Smoking, THC Ingestion Linked to Endothelial Dysfunction

TUESDAY, June 3, 2025 -- Chronic cannabis smoking and tetrahydrocannabinol (THC) ingestion are associated with endothelial dysfunction, according to a study published online May...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.